Skip to content

Research at St Andrews

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status

Research output: Contribution to journalArticle

Author(s)

Conor D. Tweed, Angela M. Crook, Rodney Dawson, Andreas H. Diacon, Timothy D. McHugh, Carl M. Mendel, Sarah K. Meredith, Lerato Mohapi, Michael E. Murphy, Andrew J. Nunn, Patrick P. J. Phillips, Kasha P. Singh, Melvin Spigelman, Stephen H. Gillespie

School/Research organisations

Abstract

Background:  The phase III REMoxTB study prospectively enrolled HIV-positive (with CD4+ count > 250 cells, not on anti-retroviral therapy) and HIV-negative patients. We investigated the incidence of adverse events and cure rates according to HIV status for patients receiving standard TB therapy in the trial.

Methods:  Forty-two HIV-positive cases were matched to 220 HIV-negative controls by age, gender, ethnicity, and trial site using coarsened exact matching. Grade 3 and 4 adverse events (AEs) were summarised by MedDRA System Organ Class. Kaplan-Meier curves for time to first grade 3 or 4 AE were constructed according to HIV status with hazard ratios calculated. Patients were considered cured if they were culture negative 18 months after commencing therapy with ≥2 consecutive negative culture results.

Results:  Twenty of 42 (47.6%) HIV-positive and 34 of 220 (15.5%) HIV-negative patients experienced ≥1 grade 3 or 4 AE, respectively. The majority of these were hepatobiliary disorders that accounted for 12 of 40 (30.0%) events occurring in 6 of 42 (14.3%) HIV-positive patients and for 15 of 60 (25.0%) events occurring in 9 of 220 (4.1%) HIV-negative patients. The median time to first grade 3 or 4 AE was 54 days (IQR 15.5–59.0) for HIV-positive and 29.5 days (IQR 9.0–119.0) for HIV-negative patients, respectively. The hazard ratio for experiencing a grade 3 or 4 AE among HIV-positive patients was 3.25 (95% CI 1.87–5.66, p < 0.01). Cure rates were similar, with 38 of 42 (90.5%) HIV-positive and 195 of 220 (88.6%) HIV-negative patients (p = 0.73) cured at 18 months.

Conclusions: HIV-positive patients receiving standard TB therapy in the REMoxTB study were at greater risk of adverse events during treatment but cure rates were similar when compared to a matched sample of HIV-negative patients.
Close

Details

Original languageEnglish
Article number152
Number of pages9
JournalBMC Pulmonary Medicine
Volume19
DOIs
Publication statusPublished - 14 Aug 2019

    Research areas

  • Tuberculosis, Clinical trials, HIV, Adverse events

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

    Tweed, C. D., Crook, A. M., Amukoye, E. I., Dawson, R., Diacon, A. H., Hanekom, M., McHugh, T. D., Mendel, C. M., Meredith, S. K., Murphy, M. E., Murthy, S. E., Nunn, A. J., Phillips, P. P. J., Singh, K. P., Spigelman, M., Wills, G. H. & Gillespie, S. H., 11 Jul 2018, In : BMC Infectious Diseases. 18, 11 p., 317.

    Research output: Contribution to journalArticle

  2. Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study

    Tweed, C. D., Wills, G. H., Crook, A. M., Dawson, R., Diacon, A. H., Louw, C. E., McHugh, T. D., Mendel, C., Meredith, S., Mohapi, L., Murphy, M. E., Murray, S., Murthy, S., Nunn, A. J., Phillips, P. P. J., Singh, K., Spigelman, M. & Gillespie, S. H., 28 Mar 2018, In : BMC Medicine. 16, 10 p., 46.

    Research output: Contribution to journalArticle

  3. Modelling the effects of environmental heterogeneity within the lung on the tuberculosis life-cycle

    Pitcher, M. J., Bowness, R., Dobson, S. A., Eftimie, R. & Gillespie, S. H., 6 Aug 2020, In : Journal of Theoretical Biology. 506, 18 p., 110381.

    Research output: Contribution to journalArticle

  4. Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteria

    Heyckendorf, J., Gillespie, S. H. & Ruhwald, M., Dec 2020, In : EBioMedicine. 62, 2 p., 103117.

    Research output: Contribution to journalComment/debate

Related by journal

  1. Interactive digital interventions to promote self-management in adults with asthma: systematic review and meta-analysis

    McLean, G., Murray, E., Band, R., Moffat, K. R., Hanlon, P., Bruton, A., Thomas, M., Yardley, L. & Mair, F. S., 23 May 2016, In : BMC Pulmonary Medicine. 16, 14 p., 83.

    Research output: Contribution to journalReview article

ID: 260661536

Top